Dear Colleagues,

On behalf of the Advances in Neuroblastoma Research Association, it is our pleasure to invite you to ANR 2025 in Washington DC from May 25th – 28th, 2025.

Building on the enthusiasm that was generated from ANR 2023 Amsterdam, the US Mid-Atlantic Organizing Committee and the Scientific Steering Committee of the Americas Region are planning an exciting program that will bring together scientists, pediatric oncologists and a wide range of clinical subspecialists, students, early-stage investigators, and advocates from around the world.

The meeting will afford unique opportunities to exchange ideas and share laboratory and clinical innovations that will enable a greater understanding of the pathogenesis of neuroblastoma and evolving treatments. This is key to accelerating and advancing our shared goal of developing more effective and less toxic therapies for our patients with neuroblastoma.

ANR 2025 will be ideal for making new and reinforcing old friendships while in Washington, DC. The region is home to the National Cancer Institute, NIH, FDA, DOD and the leadership that directs much of the US biomedical research enterprise.

Washington, DC is in full bloom in May and provides a rich resource of museums, outdoor venues, and hiking trails along the Potomac River. Come and enjoy our unique blend of the contemporary and traditional ways of life in this Capital city.  

We thank you for your time and contribution to this international organization and your leadership in advancing next generation therapies for children with neuroblastoma.

We look forward to seeing you in Washington, DC! 

Carol J. Thiele PhD                                          
Chair, Mid-Atlantic Organizing Committee   
 Julie R. Park MD
President, Advances in Neuroblastoma Research Association